Integrative Analyses Reveal the Anticancer Mechanisms and Sensitivity Markers of the Next-Generation Hypomethylating Agent NTX-301

por Lim, Byungho, Yoo, Dabin, Chun, Younghwa, Go, Areum, Kim, Ji Yeon, Lee, Ha Young, Boohaker, Rebecca J., Cho, Kyung-Jin, Ahn, Sunjoo, Lee, Jin Soo, Jung, DooYoung, Choi, Gildon
Publicado 2023

The preclinical efficacy of the novel hypomethylating agent NTX-301 as a monotherapy and in combination with venetoclax in acute myeloid leukemia

por Lim, Byungho, Yoo, Dabin, Chun, Younghwa, Go, Areum, Cho, Kyung-Jin, Choi, Daeun, Jung, Myoung Eun, Lee, Ha Young, Boohaker, Rebecca J., Lee, Jin Soo, Jung, DooYoung, Choi, Gildon
Publicado 2022